These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9204223)

  • 1. Outcomes of a placebo run-in period in a head and neck cancer chemoprevention trial.
    Hudmon KS; Chamberlain RM; Frankowski RF
    Control Clin Trials; 1997 Jun; 18(3):228-40. PubMed ID: 9204223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retinoic acid paradox in cancer chemoprevention.
    Freemantle SJ; Dragnev KH; Dmitrovsky E
    J Natl Cancer Inst; 2006 Apr; 98(7):426-7. PubMed ID: 16595769
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).
    Bhatia AK; Lee JW; Pinto HA; Jacobs CD; Limburg PJ; Rubin P; Arusell RM; Dunphy EP; Khandekar JD; Reiner SA; Baez-Diaz L; Celano P; Li S; Li Y; Burtness BA; Adams GL; Pandya KJ
    Cancer; 2017 Dec; 123(23):4653-4662. PubMed ID: 28786105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
    Mayne ST; Cartmel B; Baum M; Shor-Posner G; Fallon BG; Briskin K; Bean J; Zheng T; Cooper D; Friedman C; Goodwin WJ
    Cancer Res; 2001 Feb; 61(4):1457-63. PubMed ID: 11245451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based trial of beta-carotene chemoprevention of head and neck cancer.
    Mayne ST; Zheng T; Janerich DT; Goodwin WJ; Fallon BG; Cooper DL; Friedman CD
    Adv Exp Med Biol; 1992; 320():119-27. PubMed ID: 1442276
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of head and neck cancer with retinoids: a negative result.
    Perry CF; Stevens M; Rabie I; Yarker ME; Cochrane J; Perry E; Traficante R; Coman W
    Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):198-203. PubMed ID: 15781758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
    Bairati I; Meyer F; Gélinas M; Fortin A; Nabid A; Brochet F; Mercier JP; Têtu B; Harel F; Mâsse B; Vigneault E; Vass S; del Vecchio P; Roy J
    J Natl Cancer Inst; 2005 Apr; 97(7):481-8. PubMed ID: 15812073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
    Lippman SM; Lee JJ; Karp DD; Vokes EE; Benner SE; Goodman GE; Khuri FR; Marks R; Winn RJ; Fry W; Graziano SL; Gandara DR; Okawara G; Woodhouse CL; Williams B; Perez C; Kim HW; Lotan R; Roth JA; Hong WK
    J Natl Cancer Inst; 2001 Apr; 93(8):605-18. PubMed ID: 11309437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients.
    Lee JJ; Wu X; Hildebrandt MA; Yang H; Khuri FR; Kim E; Gu J; Ye Y; Lotan R; Spitz MR; Hong WK
    Cancer Prev Res (Phila); 2011 Feb; 4(2):185-93. PubMed ID: 21292633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of chemoprevention of head and neck cancer.
    Benner SE; Lippman SM; Hong WK
    Oncology (Williston Park); 1992 Aug; 6(8):61-6; discussion 66-8, 71 passim. PubMed ID: 1386997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck.
    Lippman SM; Spitz MR; Huber MH; Hong WK
    Curr Opin Oncol; 1995 May; 7(3):234-41. PubMed ID: 7654825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of vitamin A in the prevention of loco-regional recurrence and second primaries in head and neck cancer.
    Jyothirmayi R; Ramadas K; Varghese C; Jacob R; Nair MK; Sankaranarayanan R
    Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):373-6. PubMed ID: 9039219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of squamous cell carcinoma of the head and neck.
    Wrangle JM; Khuri FR
    Curr Opin Oncol; 2007 May; 19(3):180-7. PubMed ID: 17414634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of head and neck cancer: an update.
    Papadimitrakopoulou VA
    Curr Opin Oncol; 2002 May; 14(3):318-22. PubMed ID: 11981278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplemental beta-carotene, smoking, and urinary F2-isoprostane excretion in patients with prior early stage head and neck cancer.
    Mayne ST; Walter M; Cartmel B; Goodwin WJ; Blumberg J
    Nutr Cancer; 2004; 49(1):1-6. PubMed ID: 15454352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up.
    Seixas-Silva JA; Richards T; Khuri FR; Wieand HS; Kim E; Murphy B; Francisco M; Hong WK; Shin DM
    Arch Otolaryngol Head Neck Surg; 2005 Apr; 131(4):304-7. PubMed ID: 15837897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
    Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
    J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.